{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:19:01Z","timestamp":1789593541053,"version":"build-2803163510"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific Research Fund of Zhejiang Provincial Education Department","award":["Y202558079"],"award-info":[{"award-number":["Y202558079"]}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2024QC193"],"award-info":[{"award-number":["ZR2024QC193"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023MC013"],"award-info":[{"award-number":["ZR2023MC013"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018546","name":"Postdoctoral Innovation Project of Shandong Province","doi-asserted-by":"publisher","award":["SDCX-ZG-202303003"],"award-info":[{"award-number":["SDCX-ZG-202303003"]}],"id":[{"id":"10.13039\/501100018546","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-02979-w","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T13:25:15Z","timestamp":1780925115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nonsense-mediated mRNA decay: friend or foe in cancer biology?"],"prefix":"10.1186","volume":"24","author":[{"given":"Yuhui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghai","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tangliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"2979_CR1","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nrm4063","volume":"16","author":"S Lykke-Andersen","year":"2015","unstructured":"Lykke-Andersen S, Jensen TH. Nonsense-mediated mRNA decay: an intricate machinery that shapes transcriptomes. Nat Rev Mol Cell Biol. 2015;16:665\u201377.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2979_CR2","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/nar\/gkw010","volume":"44","author":"N Hug","year":"2016","unstructured":"Hug N, Longman D, Caceres JF. Mechanism and regulation of the nonsense-mediated decay pathway. Nucleic Acids Res. 2016;44:1483\u201395.","journal-title":"Nucleic Acids Res"},{"key":"2979_CR3","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/nar\/gkx1272","volume":"46","author":"X Han","year":"2018","unstructured":"Han X, Wei Y, Wang H, Wang F, Ju Z, Li T. Nonsense-mediated mRNA decay: a \u2018nonsense\u2019 pathway makes sense in stem cell biology. Nucleic Acids Res. 2018;46:1038\u201351.","journal-title":"Nucleic Acids Res"},{"key":"2979_CR4","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1038\/s41588-019-0517-5","volume":"51","author":"RGH Lindeboom","year":"2019","unstructured":"Lindeboom RGH, Vermeulen M, Lehner B, Supek F. The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy. Nat Genet. 2019;51:1645\u201351.","journal-title":"Nat Genet"},{"key":"2979_CR5","doi-asserted-by":"publisher","first-page":"102356","DOI":"10.1016\/j.gde.2025.102356","volume":"93","author":"K Tan","year":"2025","unstructured":"Tan K, Wilkinson MF. Biological roles of nonsense-mediated RNA decay: insights from the nervous system. Curr Opin Genet Dev. 2025;93:102356.","journal-title":"Curr Opin Genet Dev"},{"key":"2979_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov"},{"key":"2979_CR7","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1158\/2159-8290.CD-24-0861","volume":"15","author":"R Bhattacharya","year":"2025","unstructured":"Bhattacharya R, Avdieiev SS, Bukkuri A, Whelan CJ, Gatenby RA, Tsai KY, Brown JS. The Hallmarks of Cancer as Eco-Evolutionary Processes. Cancer Discov. 2025;15:685\u2013701.","journal-title":"Cancer Discov"},{"key":"2979_CR8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41568-022-00481-2","volume":"22","author":"K Tan","year":"2022","unstructured":"Tan K, Stupack DG, Wilkinson MF. Nonsense-mediated RNA decay: an emerging modulator of malignancy. Nat Rev Cancer. 2022;22:437\u201351.","journal-title":"Nat Rev Cancer"},{"key":"2979_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12943-021-01364-0","volume":"20","author":"G Nogueira","year":"2021","unstructured":"Nogueira G, Fernandes R, Garcia-Moreno JF, Romao L. Nonsense-mediated RNA decay and its bipolar function in cancer. Mol Cancer. 2021;20:72.","journal-title":"Mol Cancer"},{"key":"2979_CR10","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1042\/BCJ20210556","volume":"479","author":"J Mailliot","year":"2022","unstructured":"Mailliot J, Vivoli-Vega M, Schaffitzel C. No-nonsense: insights into the functional interplay of nonsense-mediated mRNA decay factors. Biochem J. 2022;479:973\u201393.","journal-title":"Biochem J"},{"key":"2979_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13578-017-0153-7","volume":"7","author":"A Nickless","year":"2017","unstructured":"Nickless A, Bailis JM, You Z. Control of gene expression through the nonsense-mediated RNA decay pathway. Cell Biosci. 2017;7:26.","journal-title":"Cell Biosci"},{"key":"2979_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.tig.2020.08.010","volume":"37","author":"Z Yi","year":"2021","unstructured":"Yi Z, Sanjeev M, Singh G. The Branched Nature of the Nonsense-Mediated mRNA Decay Pathway. Trends Genet. 2021;37:143\u201359.","journal-title":"Trends Genet"},{"key":"2979_CR13","doi-asserted-by":"crossref","unstructured":"Schlautmann LP, Gehring NH. A Day in the Life of the Exon Junction Complex. Biomolecules. 2020;10:866.","DOI":"10.3390\/biom10060866"},{"key":"2979_CR14","doi-asserted-by":"publisher","first-page":"6860","DOI":"10.1093\/emboj\/19.24.6860","volume":"19","author":"H Le Hir","year":"2000","unstructured":"Le Hir H, Izaurralde E, Maquat LE, Moore MJ. The spliceosome deposits multiple proteins 20\u201324 nucleotides upstream of mRNA exon-exon junctions. EMBO J. 2000;19:6860\u20139.","journal-title":"EMBO J"},{"key":"2979_CR15","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.1093\/emboj\/20.17.4987","volume":"20","author":"H Le Hir","year":"2001","unstructured":"Le Hir H, Gatfield D, Izaurralde E, Moore MJ. The exon-exon junction complex provides a binding platform for factors involved in mRNA export and nonsense-mediated mRNA decay. EMBO J. 2001;20:4987\u201397.","journal-title":"EMBO J"},{"key":"2979_CR16","doi-asserted-by":"publisher","first-page":"6424","DOI":"10.1093\/emboj\/20.22.6424","volume":"20","author":"N Kataoka","year":"2001","unstructured":"Kataoka N, Diem MD, Kim VN, Yong J, Dreyfuss G. Magoh, a human homolog of Drosophila mago nashi protein, is a component of the splicing-dependent exon-exon junction complex. EMBO J. 2001;20:6424\u201333.","journal-title":"EMBO J"},{"key":"2979_CR17","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1093\/emboj\/20.8.2062","volume":"20","author":"VN Kim","year":"2001","unstructured":"Kim VN, Yong J, Kataoka N, Abel L, Diem MD, Dreyfuss G. The Y14 protein communicates to the cytoplasm the position of exon-exon junctions. EMBO J. 2001;20:2062\u20138.","journal-title":"EMBO J"},{"key":"2979_CR18","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0092-8674(01)00475-5","volume":"106","author":"Y Ishigaki","year":"2001","unstructured":"Ishigaki Y, Li X, Serin G, Maquat LE. Evidence for a pioneer round of mRNA translation: mRNAs subject to nonsense-mediated decay in mammalian cells are bound by CBP80 and CBP20. Cell. 2001;106:607\u201317.","journal-title":"Cell"},{"key":"2979_CR19","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.1093\/emboj\/cdf345","volume":"21","author":"F Lejeune","year":"2002","unstructured":"Lejeune F, Ishigaki Y, Li X, Maquat LE. The exon junction complex is detected on CBP80-bound but not eIF4E-bound mRNA in mammalian cells: dynamics of mRNP remodeling. EMBO J. 2002;21:3536\u201345.","journal-title":"EMBO J"},{"key":"2979_CR20","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1093\/emboj\/17.12.3484","volume":"17","author":"R Thermann","year":"1998","unstructured":"Thermann R, Neu-Yilik G, Deters A, Frede U, Wehr K, Hagemeier C, Hentze MW, Kulozik AE. Binary specification of nonsense codons by splicing and cytoplasmic translation. EMBO J. 1998;17:3484\u201394.","journal-title":"EMBO J"},{"key":"2979_CR21","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S0968-0004(98)01208-0","volume":"23","author":"NAGYE MAQUAT","year":"1998","unstructured":"MAQUAT NAGYE. A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. Trends Biochem Sci. 1998;23:198\u20139.","journal-title":"Trends Biochem Sci"},{"key":"2979_CR22","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.cell.2009.02.042","volume":"137","author":"NH Gehring","year":"2009","unstructured":"Gehring NH, Lamprinaki S, Kulozik AE, Hentze MW. Disassembly of exon junction complexes by PYM. Cell. 2009;137:536\u201348.","journal-title":"Cell"},{"key":"2979_CR23","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1101\/gad.1389006","volume":"20","author":"I Kashima","year":"2006","unstructured":"Kashima I, Yamashita A, Izumi N, Kataoka N, Morishita R, Hoshino S, Ohno M, Dreyfuss G, Ohno S. Binding of a novel SMG-1-Upf1-eRF1-eRF3 complex (SURF) to the exon junction complex triggers Upf1 phosphorylation and nonsense-mediated mRNA decay. Genes Dev. 2006;20:355\u201367.","journal-title":"Genes Dev"},{"key":"2979_CR24","doi-asserted-by":"publisher","first-page":"10585","DOI":"10.1038\/ncomms10585","volume":"7","author":"R Melero","year":"2016","unstructured":"Melero R, Hug N, Lopez-Perrote A, Yamashita A, Caceres JF, Llorca O. The RNA helicase DHX34 functions as a scaffold for SMG1-mediated UPF1 phosphorylation. Nat Commun. 2016;7:10585.","journal-title":"Nat Commun"},{"key":"2979_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nsmb1330","volume":"15","author":"H Chamieh","year":"2008","unstructured":"Chamieh H, Ballut L, Bonneau F, Le Hir H. NMD factors UPF2 and UPF3 bridge UPF1 to the exon junction complex and stimulate its RNA helicase activity. Nat Struct Mol Biol. 2008;15:85\u201393.","journal-title":"Nat Struct Mol Biol"},{"key":"2979_CR26","doi-asserted-by":"publisher","first-page":"7600","DOI":"10.1093\/nar\/gkv668","volume":"43","author":"A Deniaud","year":"2015","unstructured":"Deniaud A, Karuppasamy M, Bock T, Masiulis S, Huard K, Garzoni F, Kerschgens K, Hentze MW, Kulozik AE, Beck M, et al. A network of SMG-8, SMG-9 and SMG-1\u00a0C-terminal insertion domain regulates UPF1 substrate recruitment and phosphorylation. Nucleic Acids Res. 2015;43:7600\u201311.","journal-title":"Nucleic Acids Res"},{"key":"2979_CR27","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.1016\/j.molcel.2024.11.022","volume":"84","author":"SH Boo","year":"2024","unstructured":"Boo SH, Shin MK, Hwang HJ, Hwang H, Chang S, Kim T, Baek D, Kim YK. Circular RNAs trigger nonsense-mediated mRNA decay. Mol Cell. 2024;84:4862\u2013e48774867.","journal-title":"Mol Cell"},{"key":"2979_CR28","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41580-019-0126-2","volume":"20","author":"T Kurosaki","year":"2019","unstructured":"Kurosaki T, Popp MW, Maquat LE. Quality and quantity control of gene expression by nonsense-mediated mRNA decay. Nat Rev Mol Cell Biol. 2019;20:406\u201320.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2979_CR29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s13059-021-02439-3","volume":"22","author":"ED Karousis","year":"2021","unstructured":"Karousis ED, Gypas F, Zavolan M, Muhlemann O. Nanopore sequencing reveals endogenous NMD-targeted isoforms in human cells. Genome Biol. 2021;22:223.","journal-title":"Genome Biol"},{"key":"2979_CR30","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1261\/rna.038893.113","volume":"19","author":"S Metze","year":"2013","unstructured":"Metze S, Herzog VA, Ruepp MD, Muhlemann O. Comparison of EJC-enhanced and EJC-independent NMD in human cells reveals two partially redundant degradation pathways. RNA. 2013;19:1432\u201348.","journal-title":"RNA"},{"key":"2979_CR31","doi-asserted-by":"publisher","first-page":"114074","DOI":"10.1016\/j.celrep.2024.114074","volume":"43","author":"D Musaev","year":"2024","unstructured":"Musaev D, Abdelmessih M, Vejnar CE, Yartseva V, Weiss LA, Strayer EC, Takacs CM, Giraldez AJ. UPF1 regulates mRNA stability by sensing poorly translated coding sequences. Cell Rep. 2024;43:114074.","journal-title":"Cell Rep"},{"key":"2979_CR32","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1093\/nar\/gkr791","volume":"40","author":"Y Okada-Katsuhata","year":"2012","unstructured":"Okada-Katsuhata Y, Yamashita A, Kutsuzawa K, Izumi N, Hirahara F, Ohno S. N- and C-terminal Upf1 phosphorylations create binding platforms for SMG-6 and SMG-5:SMG-7 during NMD. Nucleic Acids Res. 2012;40:1251\u201366.","journal-title":"Nucleic Acids Res"},{"key":"2979_CR33","doi-asserted-by":"crossref","unstructured":"Nagar P, Islam MR, Rahman MA. Nonsense-Mediated mRNA Decay as a Mediator of Tumorigenesis. Genes (Basel). 2023;14:357.","DOI":"10.3390\/genes14020357"},{"key":"2979_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nsmb.1530","volume":"16","author":"AB Eberle","year":"2009","unstructured":"Eberle AB, Lykke-Andersen S, Muhlemann O, Jensen TH. SMG6 promotes endonucleolytic cleavage of nonsense mRNA in human cells. Nat Struct Mol Biol. 2009;16:49\u201355.","journal-title":"Nat Struct Mol Biol"},{"key":"2979_CR35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/nar\/gku1258","volume":"43","author":"SA Schmidt","year":"2015","unstructured":"Schmidt SA, Foley PL, Jeong DH, Rymarquis LA, Doyle F, Tenenbaum SA, Belasco JG, Green PJ. Identification of SMG6 cleavage sites and a preferred RNA cleavage motif by global analysis of endogenous NMD targets in human cells. Nucleic Acids Res. 2015;43:309\u201323.","journal-title":"Nucleic Acids Res"},{"key":"2979_CR36","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S1097-2765(03)00349-6","volume":"12","author":"F Lejeune","year":"2003","unstructured":"Lejeune F, Li X, Maquat LE. Nonsense-mediated mRNA decay in mammalian cells involves decapping, deadenylating, and exonucleolytic activities. Mol Cell. 2003;12:675\u201387.","journal-title":"Mol Cell"},{"key":"2979_CR37","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.molcel.2004.10.013","volume":"16","author":"L Unterholzner","year":"2004","unstructured":"Unterholzner L, Izaurralde E. SMG7 acts as a molecular link between mRNA surveillance and mRNA decay. Mol Cell. 2004;16:587\u201396.","journal-title":"Mol Cell"},{"key":"2979_CR38","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1101\/gr.280046.124","volume":"35","author":"MJ Viscardi","year":"2025","unstructured":"Viscardi MJ, Sehgal E, Arribere JA. Endonucleolytic cleavage is the primary mechanism of decay elicited by C. elegans nonsense-mediated mRNA decay. Genome Res. 2025;35:1337\u201348.","journal-title":"Genome Res"},{"key":"2979_CR39","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1038\/s41467-021-24046-3","volume":"12","author":"V Boehm","year":"2021","unstructured":"Boehm V, Kueckelmann S, Gerbracht JV, Kallabis S, Britto-Borges T, Altmuller J, Kruger M, Dieterich C, Gehring NH. SMG5-SMG7 authorize nonsense-mediated mRNA decay by enabling SMG6 endonucleolytic activity. Nat Commun. 2021;12:3965.","journal-title":"Nat Commun"},{"key":"2979_CR40","doi-asserted-by":"crossref","unstructured":"Modena MS, Wohlenberg CM, Viscardi MJ, Dunn CR, Haag BL, Arribere JA. The PIN domain of SMG-5 functionally interacts with SMG-6 to stimulate NMD. RNA. 2026; 32(6):858\u201369.","DOI":"10.1261\/rna.080653.125"},{"key":"2979_CR41","doi-asserted-by":"crossref","unstructured":"Kurscheidt K, Theunissen S, Pasquali N, Becker K, Boehm V, Conti E, Gehring NH. Composite SMG5-SMG6 PIN domain formation is essential for NMD. Nat Commun. 2026;17(1):1934.","DOI":"10.1038\/s41467-026-69819-w"},{"key":"2979_CR42","doi-asserted-by":"crossref","unstructured":"Arpa ES, Taschner M, De Matos M, Jonas S, Gatfield D. Active Site Assembly by SMG5 as a Mechanism for SMG6 Endonuclease Licencing in Nonsense-mediated mRNA Decay. J Mol Biol. 2026:169734.","DOI":"10.1016\/j.jmb.2026.169734"},{"key":"2979_CR43","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1038\/sj.emboj.7601628","volume":"26","author":"WK Chan","year":"2007","unstructured":"Chan WK, Huang L, Gudikote JP, Chang YF, Imam JS, MacLean JA 2nd, Wilkinson MF. An alternative branch of the nonsense-mediated decay pathway. EMBO J. 2007;26:1820\u201330.","journal-title":"EMBO J"},{"key":"2979_CR44","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.molcel.2005.08.012","volume":"20","author":"NH Gehring","year":"2005","unstructured":"Gehring NH, Kunz JB, Neu-Yilik G, Breit S, Viegas MH, Hentze MW, Kulozik AE. Exon-junction complex components specify distinct routes of nonsense-mediated mRNA decay with differential cofactor requirements. Mol Cell. 2005;20:65\u201375.","journal-title":"Mol Cell"},{"key":"2979_CR45","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/ng.3664","volume":"48","author":"RGH Lindeboom","year":"2016","unstructured":"Lindeboom RGH, Supek F, Lehner B. The rules and impact of nonsense-mediated mRNA decay in human cancers. Nat Genet. 2016;48:1112\u20138.","journal-title":"Nat Genet"},{"key":"2979_CR46","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1158\/2159-8290.CD-24-0097","volume":"14","author":"MP Alcolea","year":"2024","unstructured":"Alcolea MP, Alonso-Curbelo D, Ambrogio C, Bullman S, Correia AL, Ernst A, Halbrook CJ, Kelly GL, Lund AW, Quail DF, et al. Cancer Hallmarks: Piecing the Puzzle Together. Cancer Discov. 2024;14:674\u201382.","journal-title":"Cancer Discov"},{"key":"2979_CR47","doi-asserted-by":"publisher","first-page":"7203","DOI":"10.1038\/s41467-021-27423-0","volume":"12","author":"H Sato","year":"2021","unstructured":"Sato H, Singer RH. Cellular variability of nonsense-mediated mRNA decay. Nat Commun. 2021;12:7203.","journal-title":"Nat Commun"},{"key":"2979_CR48","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s13059-025-03727-y","volume":"26","author":"G Palou-Marquez","year":"2025","unstructured":"Palou-Marquez G, Supek F. Variable efficiency of nonsense-mediated mRNA decay across human tissues, tumors and individuals. Genome Biol. 2025;26:316.","journal-title":"Genome Biol"},{"key":"2979_CR49","doi-asserted-by":"crossref","unstructured":"Tan K, Sebat J, Wilkinson MF. Cell type- and factor-specific nonsense-mediated RNA decay. Nucleic Acids Res. 2025;53:gkaf395.","DOI":"10.1093\/nar\/gkaf395"},{"key":"2979_CR50","doi-asserted-by":"publisher","first-page":"e1007467","DOI":"10.1371\/journal.pcbi.1007467","volume":"15","author":"B Zhao","year":"2019","unstructured":"Zhao B, Pritchard JR. Evolution of the nonsense-mediated decay pathway is associated with decreased cytolytic immune infiltration. PLoS Comput Biol. 2019;15:e1007467.","journal-title":"PLoS Comput Biol"},{"key":"2979_CR51","doi-asserted-by":"publisher","first-page":"e2300361","DOI":"10.1002\/pmic.202300361","volume":"24","author":"P Periasamy","year":"2024","unstructured":"Periasamy P, Joseph C, Campos A, Rajandran S, Batho C, Hudson JE, Sivakumaran H, Kore H, Datta K, Yeong J, Gowda H. Regulation of non-canonical proteins from diverse origins through the nonsense-mediated mRNA decay pathway. Proteomics. 2024;24:e2300361.","journal-title":"Proteomics"},{"key":"2979_CR52","doi-asserted-by":"publisher","first-page":"701454","DOI":"10.3389\/fphar.2021.701454","volume":"12","author":"X Jin","year":"2021","unstructured":"Jin X, Yin J, Zhu H, Li W, Yu K, Liu M, Zhang X, Lu M, Wan Z, Huang X. SMG9 Serves as an Oncogene to Promote the Tumor Progression via EMT and Wnt\/beta-Catenin Signaling Pathway in Hepatocellular Carcinoma. Front Pharmacol. 2021;12:701454.","journal-title":"Front Pharmacol"},{"key":"2979_CR53","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41389-018-0079-x","volume":"7","author":"A Bokhari","year":"2018","unstructured":"Bokhari A, Jonchere V, Lagrange A, Bertrand R, Svrcek M, Marisa L, Buhard O, Greene M, Demidova A, Jia J, et al. Targeting nonsense-mediated mRNA decay in colorectal cancers with microsatellite instability. Oncogenesis. 2018;7:70.","journal-title":"Oncogenesis"},{"key":"2979_CR54","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13046-016-0286-2","volume":"35","author":"L Chang","year":"2016","unstructured":"Chang L, Li C, Guo T, Wang H, Ma W, Yuan Y, Liu Q, Ye Q, Liu Z. The human RNA surveillance factor UPF1 regulates tumorigenesis by targeting Smad7 in hepatocellular carcinoma. J Exp Clin Cancer Res. 2016;35:8.","journal-title":"J Exp Clin Cancer Res"},{"key":"2979_CR55","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.canlet.2017.06.021","volume":"403","author":"L Cao","year":"2017","unstructured":"Cao L, Qi L, Zhang L, Song W, Yu Y, Xu C, Li L, Guo Y, Yang L, Liu C, et al. Human nonsense-mediated RNA decay regulates EMT by targeting the TGF-\u03b2 signaling pathway in lung adenocarcinoma. Cancer Lett. 2017;403:246\u201359.","journal-title":"Cancer Lett"},{"key":"2979_CR56","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/nm.3548","volume":"20","author":"C Liu","year":"2014","unstructured":"Liu C, Karam R, Zhou Y, Su F, Ji Y, Li G, Xu G, Lu L, Wang C, Song M, et al. The UPF1 RNA surveillance gene is commonly mutated in pancreatic adenosquamous carcinoma. Nat Med. 2014;20:596\u20138.","journal-title":"Nat Med"},{"key":"2979_CR57","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1172\/JCI86508","volume":"126","author":"J Lu","year":"2016","unstructured":"Lu J, Plank TD, Su F, Shi X, Liu C, Ji Y, Li S, Huynh A, Shi C, Zhu B, et al. The nonsense-mediated RNA decay pathway is disrupted in inflammatory myofibroblastic tumors. J Clin Invest. 2016;126:3058\u201362.","journal-title":"J Clin Invest"},{"key":"2979_CR58","doi-asserted-by":"crossref","unstructured":"Polaski JT, Udy DB, Escobar-Hoyos LF, Askan G, Leach SD, Ventura A, Kannan R, Bradley RK. The origins and consequences of UPF1 variants in pancreatic adenosquamous carcinoma. Elife. 2021;10:e62209.","DOI":"10.7554\/eLife.62209"},{"key":"2979_CR59","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1101\/gad.290940.116","volume":"31","author":"P Falletta","year":"2017","unstructured":"Falletta P, Sanchez-Del-Campo L, Chauhan J, Effern M, Kenyon A, Kershaw CJ, Siddaway R, Lisle R, Freter R, Daniels MJ, et al. Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma. Genes Dev. 2017;31:18\u201333.","journal-title":"Genes Dev"},{"key":"2979_CR60","doi-asserted-by":"crossref","unstructured":"Vendramin R, Katopodi V, Cinque S, Konnova A, Knezevic Z, Adnane S, Verheyden Y, Karras P, Demesmaeker E, Bosisio FM, et al. Activation of the integrated stress response confers vulnerability to mitoribosome-targeting antibiotics in melanoma. J Exp Med. 2021;218:e20210571.","DOI":"10.1084\/jem.20210571"},{"key":"2979_CR61","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/humu.20763","volume":"29","author":"M Mort","year":"2008","unstructured":"Mort M, Ivanov D, Cooper DN, Chuzhanova NA. A meta-analysis of nonsense mutations causing human genetic disease. Hum Mutat. 2008;29:1037\u201347.","journal-title":"Hum Mutat"},{"key":"2979_CR62","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1093\/hmg\/11.23.2805","volume":"11","author":"L Perrin-Vidoz","year":"2002","unstructured":"Perrin-Vidoz L, Sinilnikova OM, Stoppa-Lyonnet D, Lenoir GM, Mazoyer S. The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons. Hum Mol Genet. 2002;11:2805\u201314.","journal-title":"Hum Mol Genet"},{"key":"2979_CR63","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/sj.onc.1209033","volume":"25","author":"MD Ware","year":"2006","unstructured":"Ware MD, DeSilva D, Sinilnikova OM, Stoppa-Lyonnet D, Tavtigian SV, Mazoyer S. Does nonsense-mediated mRNA decay explain the ovarian cancer cluster region of the BRCA2 gene? Oncogene. 2006;25:323\u20138.","journal-title":"Oncogene"},{"key":"2979_CR64","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/humu.20590","volume":"29","author":"O Anczukow","year":"2008","unstructured":"Anczukow O, Ware MD, Buisson M, Zetoune AB, Stoppa-Lyonnet D, Sinilnikova OM, Mazoyer S. Does the nonsense-mediated mRNA decay mechanism prevent the synthesis of truncated BRCA1, CHK2, and p53 proteins? Hum Mutat. 2008;29:65\u201373.","journal-title":"Hum Mutat"},{"key":"2979_CR65","doi-asserted-by":"publisher","first-page":"5422","DOI":"10.1182\/blood-2006-11-057208","volume":"109","author":"M Pinyol","year":"2007","unstructured":"Pinyol M, Bea S, Pla L, Ribrag V, Bosq J, Rosenwald A, Campo E, Jares P. Inactivation of RB1 in mantle-cell lymphoma detected by nonsense-mediated mRNA decay pathway inhibition and microarray analysis. Blood. 2007;109:5422\u20139.","journal-title":"Blood"},{"key":"2979_CR66","doi-asserted-by":"publisher","first-page":"10878","DOI":"10.1074\/jbc.270.18.10878","volume":"270","author":"JC Reddy","year":"1995","unstructured":"Reddy JC, Morris JC, Wang J, English MA, Haber DA, Shi Y, Licht JD. WT1-mediated transcriptional activation is inhibited by dominant negative mutant proteins. J Biol Chem. 1995;270:10878\u201384.","journal-title":"J Biol Chem"},{"key":"2979_CR67","doi-asserted-by":"publisher","first-page":"15943","DOI":"10.1038\/ncomms15943","volume":"8","author":"Z Hu","year":"2017","unstructured":"Hu Z, Yau C, Ahmed AA. A pan-cancer genome-wide analysis reveals tumour dependencies by induction of nonsense-mediated decay. Nat Commun. 2017;8:15943.","journal-title":"Nat Commun"},{"key":"2979_CR68","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1128\/MCB.05704-11","volume":"31","author":"D Wang","year":"2011","unstructured":"Wang D, Zavadil J, Martin L, Parisi F, Friedman E, Levy D, Harding H, Ron D, Gardner LB. Inhibition of nonsense-mediated RNA decay by the tumor microenvironment promotes tumorigenesis. Mol Cell Biol. 2011;31:3670\u201380.","journal-title":"Mol Cell Biol"},{"key":"2979_CR69","doi-asserted-by":"publisher","first-page":"R8","DOI":"10.1186\/gb-2004-5-2-r8","volume":"5","author":"RT Hillman","year":"2004","unstructured":"Hillman RT, Green RE, Brenner SE. An unappreciated role for RNA surveillance. Genome Biol. 2004;5:R8.","journal-title":"Genome Biol"},{"key":"2979_CR70","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.1016\/j.molcel.2025.08.015","volume":"85","author":"V Boehm","year":"2025","unstructured":"Boehm V, Wallmeroth D, Wulf PO, Popp O, Teixeira Alves LG, Reinecke L, Riedel M, Wyler E, Franitza M, Becker K, et al. Rapid UPF1 depletion illuminates the temporal dynamics of the NMD-regulated human transcriptome. Mol Cell. 2025;85:3524\u2013e35463512.","journal-title":"Mol Cell"},{"key":"2979_CR71","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-021-00486-7","volume":"6","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Qian J, Gu C, Yang Y. Alternative splicing and cancer: a systematic review. Signal Transduct Target Ther. 2021;6:78.","journal-title":"Signal Transduct Target Ther"},{"key":"2979_CR72","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41586-023-05820-3","volume":"617","author":"A Jbara","year":"2023","unstructured":"Jbara A, Lin KT, Stossel C, Siegfried Z, Shqerat H, Amar-Schwartz A, Elyada E, Mogilevsky M, Raitses-Gurevich M, Johnson JL, et al. RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer. Nature. 2023;617:147\u201353.","journal-title":"Nature"},{"key":"2979_CR73","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ccell.2015.04.006","volume":"27","author":"E Kim","year":"2015","unstructured":"Kim E, Ilagan JO, Liang Y, Daubner GM, Lee SC, Ramakrishnan A, Li Y, Chung YR, Micol JB, Murphy ME, et al. SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition. Cancer Cell. 2015;27:617\u201330.","journal-title":"Cancer Cell"},{"key":"2979_CR74","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1101\/gad.332270.119","volume":"34","author":"MA Rahman","year":"2020","unstructured":"Rahman MA, Lin KT, Bradley RK, Abdel-Wahab O, Krainer AR. Recurrent SRSF2 mutations in MDS affect both splicing and NMD. Genes Dev. 2020;34:413\u201327.","journal-title":"Genes Dev"},{"key":"2979_CR75","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ng.621","volume":"42","author":"T Ernst","year":"2010","unstructured":"Ernst T, Chase AJ, Score J, Hidalgo-Curtis CE, Bryant C, Jones AV, Waghorn K, Zoi K, Ross FM, Reiter A, et al. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat Genet. 2010;42:722\u20136.","journal-title":"Nat Genet"},{"key":"2979_CR76","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.1158\/0008-5472.CAN-20-4016","volume":"81","author":"A Cheruiyot","year":"2021","unstructured":"Cheruiyot A, Li S, Nonavinkere Srivatsan S, Ahmed T, Chen Y, Lemacon DS, Li Y, Yang Z, Wadugu BA, Warner WA, et al. Nonsense-Mediated RNA Decay Is a Unique Vulnerability of Cancer Cells Harboring SF3B1 or U2AF1 Mutations. Cancer Res. 2021;81:4499\u2013513.","journal-title":"Cancer Res"},{"key":"2979_CR77","doi-asserted-by":"crossref","unstructured":"Oh J, Pradella D, Shao C, Li H, Choi N, Ha J, Ruggiero S, Fu XD, Zheng X, Ghigna C, Shen H. Widespread Alternative Splicing Changes in Metastatic Breast Cancer Cells. Cells. 2021;10:858.","DOI":"10.3390\/cells10040858"},{"key":"2979_CR78","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41556-022-00913-z","volume":"24","author":"JJ Chan","year":"2022","unstructured":"Chan JJ, Zhang B, Chew XH, Salhi A, Kwok ZH, Lim CY, Desi N, Subramaniam N, Siemens A, Kinanti T, et al. Pan-cancer pervasive upregulation of 3\u2019 UTR splicing drives tumourigenesis. Nat Cell Biol. 2022;24:928\u201339.","journal-title":"Nat Cell Biol"},{"key":"2979_CR79","doi-asserted-by":"crossref","unstructured":"Riley JJ, Alexandru-Crivac CN, Bryce-Smith S, Wilson SA, Sudbery IM. Widespread 3\u2019 UTR splicing regulates expression of oncogene transcripts through multiple mechanisms. Nucleic Acids Res. 2025;53:gkaf700.","DOI":"10.1093\/nar\/gkaf700"},{"key":"2979_CR80","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","volume":"8","author":"N Xie","year":"2023","unstructured":"Xie N, Shen G, Gao W, Huang Z, Huang C, Fu L. Neoantigens: promising targets for cancer therapy. Signal Transduct Target Ther. 2023;8:9.","journal-title":"Signal Transduct Target Ther"},{"key":"2979_CR81","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13045-025-01732-z","volume":"18","author":"S Sun","year":"2025","unstructured":"Sun S, Liu L, Zhang J, Sun L, Shu W, Yang Z, Yao H, Zhang Z. The role of neoantigens and tumor mutational burden in cancer immunotherapy: advances, mechanisms, and perspectives. J Hematol Oncol. 2025;18:84.","journal-title":"J Hematol Oncol"},{"key":"2979_CR82","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.trecan.2024.10.008","volume":"11","author":"A Rosenberg-Mogilevsky","year":"2025","unstructured":"Rosenberg-Mogilevsky A, Siegfried Z, Karni R. Generation of tumor neoantigens by RNA splicing perturbation. Trends Cancer. 2025;11:12\u201324.","journal-title":"Trends Cancer"},{"key":"2979_CR83","doi-asserted-by":"crossref","unstructured":"Cook AL, Sur S, Dobbyn L, Watson E, Cohen JD, Ptak B, Lee BS, Paul S, Hsiue E, Popoli M et al. Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape. Elife. 2025;13:RP95952.","DOI":"10.7554\/eLife.95952.3"},{"key":"2979_CR84","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1038\/s41467-020-17526-5","volume":"11","author":"K Litchfield","year":"2020","unstructured":"Litchfield K, Reading JL, Lim EL, Xu H, Liu P, Al-Bakir M, Wong YNS, Rowan A, Funt SA, Merghoub T, et al. Escape from nonsense-mediated decay associates with anti-tumor immunogenicity. Nat Commun. 2020;11:3800.","journal-title":"Nat Commun"},{"key":"2979_CR85","doi-asserted-by":"crossref","unstructured":"Giampietri C, Petrungaro S, Conti S, Facchiano A, Filippini A, Ziparo E. Cancer Microenvironment and Endoplasmic Reticulum Stress Response. Mediators Inflamm. 2015;2015:417281.","DOI":"10.1155\/2015\/417281"},{"key":"2979_CR86","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/ng1429","volume":"36","author":"JT Mendell","year":"2004","unstructured":"Mendell JT, Sharifi NA, Meyers JL, Martinez-Murillo F, Dietz HC. Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise. Nat Genet. 2004;36:1073\u20138.","journal-title":"Nat Genet"},{"key":"2979_CR87","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1128\/MCB.02284-07","volume":"28","author":"LB Gardner","year":"2008","unstructured":"Gardner LB. Hypoxic inhibition of nonsense-mediated RNA decay regulates gene expression and the integrated stress response. Mol Cell Biol. 2008;28:3729\u201341.","journal-title":"Mol Cell Biol"},{"key":"2979_CR88","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1038\/srep02346","volume":"3","author":"F Usuki","year":"2013","unstructured":"Usuki F, Fujimura M, Yamashita A. Endoplasmic reticulum stress preconditioning attenuates methylmercury-induced cellular damage by inducing favorable stress responses. Sci Rep. 2013;3:2346.","journal-title":"Sci Rep"},{"key":"2979_CR89","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1007\/s00018-017-2537-6","volume":"74","author":"AE Goetz","year":"2017","unstructured":"Goetz AE, Wilkinson M. Stress and the nonsense-mediated RNA decay pathway. Cell Mol Life Sci. 2017;74:3509\u201331.","journal-title":"Cell Mol Life Sci"},{"key":"2979_CR90","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1038\/onc.2014.352","volume":"34","author":"L Martin","year":"2015","unstructured":"Martin L, Gardner LB. Stress-induced inhibition of nonsense-mediated RNA decay regulates intracellular cystine transport and intracellular glutathione through regulation of the cystine\/glutamate exchanger SLC7A11. Oncogene. 2015;34:4211\u20138.","journal-title":"Oncogene"},{"key":"2979_CR91","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/s41598-018-38015-2","volume":"9","author":"F Usuki","year":"2019","unstructured":"Usuki F, Yamashita A, Fujimura M. Environmental stresses suppress nonsense-mediated mRNA decay (NMD) and affect cells by stabilizing NMD-targeted gene expression. Sci Rep. 2019;9:1279.","journal-title":"Sci Rep"},{"key":"2979_CR92","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/nm.3620","volume":"20","author":"A Nickless","year":"2014","unstructured":"Nickless A, Jackson E, Marasa J, Nugent P, Mercer RW, Piwnica-Worms D, You Z. Intracellular calcium regulates nonsense-mediated mRNA decay. Nat Med. 2014;20:961\u20136.","journal-title":"Nat Med"},{"key":"2979_CR93","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1093\/brain\/awz070","volume":"142","author":"W Xu","year":"2019","unstructured":"Xu W, Bao P, Jiang X, Wang H, Qin M, Wang R, Wang T, Yang Y, Lorenzini I, Liao L, et al. Reactivation of nonsense-mediated mRNA decay protects against C9orf72 dipeptide-repeat neurotoxicity. Brain. 2019;142:1349\u201364.","journal-title":"Brain"},{"key":"2979_CR94","doi-asserted-by":"publisher","first-page":"111844","DOI":"10.1016\/j.biopha.2021.111844","volume":"141","author":"S Osman","year":"2021","unstructured":"Osman S, Raza A, Al-Zaidan L, Inchakalody VP, Merhi M, Prabhu KS, Abdelaziz N, Hydrose S, Uddin S, Dermime S. Anti-cancer effects of Tranilast: An update. Biomed Pharmacother. 2021;141:111844.","journal-title":"Biomed Pharmacother"},{"key":"2979_CR95","doi-asserted-by":"crossref","unstructured":"Mitsuno M, Kitajima Y, Ohtaka K, Kai K, Hashiguchi K, Nakamura J, Hiraki M, Noshiro H, Miyazaki K. Tranilast strongly sensitizes pancreatic cancer cells to gemcitabine via decreasing protein expression of ribonucleotide reductase 1. Int J Oncol. 2009;36:341\u20139.","DOI":"10.3892\/ijo_00000505"},{"key":"2979_CR96","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10120-017-0726-5","volume":"21","author":"H Saito","year":"2018","unstructured":"Saito H, Fushida S, Harada S, Miyashita T, Oyama K, Yamaguchi T, Tsukada T, Kinoshita J, Tajima H, Ninomiya I, Ohta T. Importance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: inhibition of growth and fibrosis by tranilast. Gastric Cancer. 2018;21:55\u201367.","journal-title":"Gastric Cancer"},{"key":"2979_CR97","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00535-017-1338-x","volume":"53","author":"A Shiozaki","year":"2018","unstructured":"Shiozaki A, Kudou M, Ichikawa D, Fujiwara H, Shimizu H, Ishimoto T, Arita T, Kosuga T, Konishi H, Komatsu S, et al. Esophageal cancer stem cells are suppressed by tranilast, a TRPV2 channel inhibitor. J Gastroenterol. 2018;53:197\u2013207.","journal-title":"J Gastroenterol"},{"key":"2979_CR98","doi-asserted-by":"crossref","unstructured":"Mariniello M, Petruzzelli R, Wanderlingh LG, La Montagna R, Carissimo A, Pane F, Amoresano A, Ilyechova EY, Galagudza MM, Catalano F, et al. Synthetic Lethality Screening Identifies FDA-Approved Drugs that Overcome ATP7B-Mediated Tolerance of Tumor Cells to Cisplatin. Cancers (Basel). 2020;12:608.","DOI":"10.3390\/cancers12030608"},{"key":"2979_CR99","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.21873\/anticanres.14311","volume":"40","author":"K Takahashi","year":"2020","unstructured":"Takahashi K, Menju T, Nishikawa S, Miyata R, Tanaka S, Yutaka Y, Yamada Y, Nakajima D, Hamaji M, Ohsumi A, et al. Tranilast Inhibits TGF-beta1-induced Epithelial-mesenchymal Transition and Invasion\/Metastasis via the Suppression of Smad4 in Human Lung Cancer Cell Lines. Anticancer Res. 2020;40:3287\u201396.","journal-title":"Anticancer Res"},{"key":"2979_CR100","first-page":"601","volume":"20","author":"M Hashemzehi","year":"2021","unstructured":"Hashemzehi M, Yavari N, Rahmani F, Asgharzadeh F, Soleimani A, Shakour N, Avan A, Hadizadeh F, Fakhraie M, Marjaneh RM, et al. Inhibition of transforming growth factor-beta by Tranilast reduces tumor growth and ameliorates fibrosis in colorectal cancer. EXCLI J. 2021;20:601\u201313.","journal-title":"EXCLI J"},{"key":"2979_CR101","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1083\/jcb.200611086","volume":"178","author":"S Durand","year":"2007","unstructured":"Durand S, Cougot N, Mahuteau-Betzer F, Nguyen CH, Grierson DS, Bertrand E, Tazi J, Lejeune F. Inhibition of nonsense-mediated mRNA decay (NMD) by a new chemical molecule reveals the dynamic of NMD factors in P-bodies. J Cell Biol. 2007;178:1145\u201360.","journal-title":"J Cell Biol"},{"key":"2979_CR102","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1158\/0008-5472.CAN-13-2235","volume":"74","author":"L Martin","year":"2014","unstructured":"Martin L, Grigoryan A, Wang D, Wang J, Breda L, Rivella S, Cardozo T, Gardner LB. Identification and characterization of small molecules that inhibit nonsense-mediated RNA decay and suppress nonsense p53 mutations. Cancer Res. 2014;74:3104\u201313.","journal-title":"Cancer Res"},{"key":"2979_CR103","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.15252\/emmm.201404461","volume":"6","author":"M Bhuvanagiri","year":"2014","unstructured":"Bhuvanagiri M, Lewis J, Putzker K, Becker JP, Leicht S, Krijgsveld J, Batra R, Turnwald B, Jovanovic B, Hauer C, et al. 5-azacytidine inhibits nonsense-mediated decay in a MYC-dependent fashion. EMBO Mol Med. 2014;6:1593\u2013609.","journal-title":"EMBO Mol Med"},{"key":"2979_CR104","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.1038\/sj.onc.1205699","volume":"21","author":"JK Christman","year":"2002","unstructured":"Christman JK. 5-Azacytidine and 5-aza-2\u2019-deoxycytidine as inhibitors of DNA methylation mechanistic studies and their implications for cancer therapy. Oncogene. 2002;21:5483\u201395.","journal-title":"Oncogene"},{"key":"2979_CR105","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.15252\/emmm.201404569","volume":"6","author":"A Shao","year":"2014","unstructured":"Shao A, Wilkinson MF. Suppressing nonsense\u2013a surprising function for 5-azacytidine. EMBO Mol Med. 2014;6:1518\u201320.","journal-title":"EMBO Mol Med"},{"key":"2979_CR106","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/s13046-021-02192-2","volume":"40","author":"R Bongiorno","year":"2021","unstructured":"Bongiorno R, Colombo MP, Lecis D. Deciphering the nonsense-mediated mRNA decay pathway to identify cancer cell vulnerabilities for effective cancer therapy. J Exp Clin Cancer Res. 2021;40:376.","journal-title":"J Exp Clin Cancer Res"},{"key":"2979_CR107","doi-asserted-by":"crossref","unstructured":"Gonzalez-Hilarion S, Beghyn T, Jia J, Debreuck N, Berte G, Mamchaoui K, Mouly V, Gruenert DC, D\u00e9prez B, Lejeune F. Rescue of nonsense mutations by amlexanox in human cells. Orphanet J Rare Dis. 2012;7:58.","DOI":"10.1186\/1750-1172-7-58"},{"key":"2979_CR108","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.jid.2017.05.011","volume":"137","author":"VS Atanasova","year":"2017","unstructured":"Atanasova VS, Jiang Q, Prisco M, Gruber C, Pinon Hofbauer J, Chen M, Has C, Bruckner-Tuderman L, McGrath JA, Uitto J, South AP. Amlexanox Enhances Premature Termination Codon Read-Through in COL7A1 and Expression of Full Length Type VII Collagen: Potential Therapy for Recessive Dystrophic Epidermolysis Bullosa. J Invest Dermatol. 2017;137:1842\u20139.","journal-title":"J Invest Dermatol"},{"key":"2979_CR109","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13059-017-1386-9","volume":"19","author":"L Huang","year":"2018","unstructured":"Huang L, Low A, Damle SS, Keenan MM, Kuntz S, Murray SF, Monia BP, Guo S. Antisense suppression of the nonsense mediated decay factor Upf3b as a potential treatment for diseases caused by nonsense mutations. Genome Biol. 2018;19:4.","journal-title":"Genome Biol"},{"key":"2979_CR110","doi-asserted-by":"publisher","first-page":"11022","DOI":"10.1093\/nar\/gkab882","volume":"49","author":"M Palma","year":"2021","unstructured":"Palma M, Leroy C, Salome-Desnoulez S, Werkmeister E, Kong R, Mongy M, Le Hir H, Lejeune F. A role for AKT1 in nonsense-mediated mRNA decay. Nucleic Acids Res. 2021;49:11022\u201337.","journal-title":"Nucleic Acids Res"},{"key":"2979_CR111","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1016\/j.molcel.2022.05.013","volume":"82","author":"H Cho","year":"2022","unstructured":"Cho H, Abshire ET, Popp MW, Proschel C, Schwartz JL, Yeo GW, Maquat LE. AKT constitutes a signal-promoted alternative exon-junction complex that regulates nonsense-mediated mRNA decay. Mol Cell. 2022;82:2779\u2013e27962710.","journal-title":"Mol Cell"},{"key":"2979_CR112","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1007\/s00018-021-03809-7","volume":"78","author":"P Martins-Dias","year":"2021","unstructured":"Martins-Dias P, Romao L. Nonsense suppression therapies in human genetic diseases. Cell Mol Life Sci. 2021;78:4677\u2013701.","journal-title":"Cell Mol Life Sci"},{"key":"2979_CR113","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.pharmthera.2012.07.007","volume":"136","author":"HL Lee","year":"2012","unstructured":"Lee HL, Dougherty JP. Pharmaceutical therapies to recode nonsense mutations in inherited diseases. Pharmacol Ther. 2012;136:227\u201366.","journal-title":"Pharmacol Ther"},{"key":"2979_CR114","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev-genom-091212-153527","volume":"15","author":"KM Keeling","year":"2014","unstructured":"Keeling KM, Xue X, Gunn G, Bedwell DM. Therapeutics based on stop codon readthrough. Annu Rev Genomics Hum Genet. 2014;15:371\u201394.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"2979_CR115","doi-asserted-by":"crossref","unstructured":"Morais P, Adachi H, Yu YT. Suppression of Nonsense Mutations by New Emerging Technologies. Int J Mol Sci. 2020;21:4394.","DOI":"10.3390\/ijms21124394"},{"key":"2979_CR116","doi-asserted-by":"crossref","unstructured":"Lombardi S, Testa MF, Pinotti M, Branchini A. Molecular Insights into Determinants of Translational Readthrough and Implications for Nonsense Suppression Approaches. Int J Mol Sci. 2020;21:9449.","DOI":"10.3390\/ijms21249449"},{"key":"2979_CR117","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.1093\/nar\/13.17.6265","volume":"13","author":"JF Burke","year":"1985","unstructured":"Burke JF, Mogg AE. Suppression of a nonsense mutation in mammalian cells in vivo by the aminoglycoside antibiotics G-418 and paromomycin. Nucleic Acids Res. 1985;13:6265\u201372.","journal-title":"Nucleic Acids Res"},{"key":"2979_CR118","doi-asserted-by":"crossref","unstructured":"Li S, Li J, Shi W, Nie Z, Zhang S, Ma F, Hu J, Chen J, Li P, Xie X. Pharmaceuticals Promoting Premature Termination Codon Readthrough: Progress in Development. Biomolecules. 2023;13:988.","DOI":"10.3390\/biom13060988"},{"key":"2979_CR119","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s10020-018-0024-7","volume":"24","author":"M Dabrowski","year":"2018","unstructured":"Dabrowski M, Bukowy-Bieryllo Z, Zietkiewicz E. Advances in therapeutic use of a drug-stimulated translational readthrough of premature termination codons. Mol Med. 2018;24:25.","journal-title":"Mol Med"},{"key":"2979_CR120","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nature05756","volume":"447","author":"EM Welch","year":"2007","unstructured":"Welch EM, Barton ER, Zhuo J, Tomizawa Y, Friesen WJ, Trifillis P, Paushkin S, Patel M, Trotta CR, Hwang S, et al. PTC124 targets genetic disorders caused by nonsense mutations. Nature. 2007;447:87\u201391.","journal-title":"Nature"},{"key":"2979_CR121","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s40268-025-00512-x","volume":"25","author":"L Bello","year":"2025","unstructured":"Bello L, Riguzzi P, Albamonte E, Astrea G, Battini R, Barp A, Berardinelli AL, Bertini ES, Brolatti N, Bruno C, et al. Opinion of the Italian Association of Myology on Ataluren for the Treatment of Nonsense Mutation Duchenne Muscular Dystrophy. Drugs R D. 2025;25:99\u2013106.","journal-title":"Drugs R D"},{"key":"2979_CR122","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1016\/j.ymthe.2025.06.002","volume":"33","author":"V Bezzerri","year":"2025","unstructured":"Bezzerri V, Cipolli M. Beyond the bench: Revitalizing ataluren development for rare genetic disorders. Mol Ther. 2025;33:2968\u20139.","journal-title":"Mol Ther"},{"key":"2979_CR123","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.molmed.2023.01.004","volume":"29","author":"S Spelier","year":"2023","unstructured":"Spelier S, van Doorn EPM, van der Ent CK, Beekman JM, Koppens MAJ. Readthrough compounds for nonsense mutations: bridging the translational gap. Trends Mol Med. 2023;29:297\u2013314.","journal-title":"Trends Mol Med"},{"key":"2979_CR124","doi-asserted-by":"crossref","unstructured":"McHugh DR, Cotton CU, Hodges CA. Synergy between Readthrough and Nonsense Mediated Decay Inhibition in a Murine Model of Cystic Fibrosis Nonsense Mutations. Int J Mol Sci. 2020;22:344.","DOI":"10.3390\/ijms22010344"},{"key":"2979_CR125","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1093\/hmg\/ddad072","volume":"32","author":"A Amar-Schwartz","year":"2023","unstructured":"Amar-Schwartz A, Cohen Y, Elhaj A, Ben-Hur V, Siegfried Z, Karni R, Dor T. Inhibition of nonsense-mediated mRNA decay may improve stop codon read-through therapy for Duchenne muscular dystrophy. Hum Mol Genet. 2023;32:2455\u201363.","journal-title":"Hum Mol Genet"},{"key":"2979_CR126","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.omtn.2023.06.018","volume":"33","author":"SH Osum","year":"2023","unstructured":"Osum SH, Oribamise EI, Corbiere S, Taisto M, Jubenville T, Coutts A, Kirstein MN, Fisher J, Moertel C, Du M, et al. Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1. Mol Ther Nucleic Acids. 2023;33:227\u201339.","journal-title":"Mol Ther Nucleic Acids"},{"key":"2979_CR127","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/s12967-023-04172-w","volume":"21","author":"L Shen","year":"2023","unstructured":"Shen L, Brown JR, Johnston SA, Altan M, Sykes KF. Predicting response and toxicity to immune checkpoint inhibitors in lung cancer using antibodies to frameshift neoantigens. J Transl Med. 2023;21:338.","journal-title":"J Transl Med"},{"key":"2979_CR128","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","volume":"20","author":"AD Waldman","year":"2020","unstructured":"Waldman AD, Fritz JM, Lenardo MJ. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol. 2020;20:651\u201368.","journal-title":"Nat Rev Immunol"},{"key":"2979_CR129","doi-asserted-by":"crossref","unstructured":"Moeckel C, Bakhl K, Georgakopoulos-Soares I, Zaravinos A. The Efficacy of Tumor Mutation Burden as a Biomarker of Response to Immune Checkpoint Inhibitors. Int J Mol Sci. 2023;24:6710.","DOI":"10.3390\/ijms24076710"},{"key":"2979_CR130","doi-asserted-by":"publisher","first-page":"101788","DOI":"10.1016\/j.tranon.2023.101788","volume":"38","author":"P Vryza","year":"2023","unstructured":"Vryza P, Fischer T, Mistakidi E, Zaravinos A. Tumor mutation burden in the prognosis and response of lung cancer patients to immune-checkpoint inhibition therapies. Transl Oncol. 2023;38:101788.","journal-title":"Transl Oncol"},{"key":"2979_CR131","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nature08999","volume":"465","author":"F Pastor","year":"2010","unstructured":"Pastor F, Kolonias D, Giangrande PH, Gilboa E. Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay. Nature. 2010;465:227\u201330.","journal-title":"Nature"},{"key":"2979_CR132","doi-asserted-by":"publisher","first-page":"102389","DOI":"10.1016\/j.isci.2021.102389","volume":"24","author":"JP Becker","year":"2021","unstructured":"Becker JP, Helm D, Rettel M, Stein F, Hernandez-Sanchez A, Urban K, Gebert J, Kloor M, Neu-Yilik G, von Knebel Doeberitz M, et al. NMD inhibition by 5-azacytidine augments presentation of immunogenic frameshift-derived neoepitopes. iScience. 2021;24:102389.","journal-title":"iScience"},{"key":"2979_CR133","doi-asserted-by":"publisher","first-page":"115919","DOI":"10.1016\/j.celrep.2025.115919","volume":"44","author":"S Zhu","year":"2025","unstructured":"Zhu S, Bai Y, Zhang D, Huang C, Qian X, Li P, Xie T, Wu Q, Liu A, Zhu T, et al. Inhibiting UPF1 methylation enhances tumor immunotherapy sensitivity by reducing nonsense-mediated mRNA decay. Cell Rep. 2025;44:115919.","journal-title":"Cell Rep"},{"key":"2979_CR134","doi-asserted-by":"publisher","first-page":"102463","DOI":"10.1016\/j.xcrm.2025.102463","volume":"6","author":"Y Wang","year":"2025","unstructured":"Wang Y, Wang Z, Wang C, Wu Y, Li J, Feng L, Hao M, Jin H, Zhou J, Wang X. Nonsense-mediated mRNA decay inhibits TRAF6-dependent anti-tumor immunity in colorectal cancer. Cell Rep Med. 2025;6:102463.","journal-title":"Cell Rep Med"},{"key":"2979_CR135","doi-asserted-by":"publisher","first-page":"114597","DOI":"10.1016\/j.isci.2025.114597","volume":"29","author":"M Barainka","year":"2026","unstructured":"Barainka M, Zheleva A, Perez-Cervera A, Villanueva H, Meraviglia-Crivelli D, Moreno B, Pastor F. Pharmacological perturbation of splicing elicits SMG1 reduction: Implications for cancer therapy. iScience. 2026;29:114597.","journal-title":"iScience"},{"key":"2979_CR136","doi-asserted-by":"publisher","first-page":"118854","DOI":"10.1016\/j.biopha.2025.118854","volume":"193","author":"C Rojo","year":"2025","unstructured":"Rojo C, Otero A, Elizalde M, Azkona M, Barbero R, Latasa MU, Uriarte I, Gutierrez-Uzquiza A, Alignani D, Guembe L, et al. Demonstration of SLU7 as a new cancer target. Biomed Pharmacother. 2025;193:118854.","journal-title":"Biomed Pharmacother"},{"key":"2979_CR137","doi-asserted-by":"crossref","unstructured":"Popp MW, Maquat LE. Attenuation of nonsense-mediated mRNA decay facilitates the response to chemotherapeutics. Nat Commun. 2015;6:6632.","DOI":"10.1038\/ncomms7632"},{"key":"2979_CR138","doi-asserted-by":"crossref","unstructured":"Zhu C, Zhang L, Zhao S, Dai W, Xu Y, Zhang Y, Zheng H, Sheng W, Xu Y. UPF1 promotes chemoresistance to oxaliplatin through regulation of TOP2A activity and maintenance of stemness in colorectal cancer. Cell Death Dis. 2021;12:519.","DOI":"10.1038\/s41419-021-03798-2"},{"key":"2979_CR139","doi-asserted-by":"crossref","unstructured":"Dyle MC, Kolakada D, Cortazar MA, Jagannathan S. How to get away with nonsense: Mechanisms and consequences of escape from nonsense-mediated RNA decay. Wiley Interdisciplinary Reviews-Rna. 2020;11:e1560.","DOI":"10.1002\/wrna.1560"},{"key":"2979_CR140","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1261\/rna.070136.118","volume":"25","author":"YK Kim","year":"2019","unstructured":"Kim YK, Maquat LE. UPFront and center in RNA decay: UPF1 in nonsense-mediated mRNA decay and beyond. RNA. 2019;25:407\u201322.","journal-title":"RNA"},{"key":"2979_CR141","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nrg2402","volume":"9","author":"O Isken","year":"2008","unstructured":"Isken O, Maquat LE. The multiple lives of NMD factors: balancing roles in gene and genome regulation. Nat Rev Genet. 2008;9:699\u2013712.","journal-title":"Nat Rev Genet"},{"key":"2979_CR142","doi-asserted-by":"crossref","unstructured":"Nguyen LS, Wilkinson MF, Gecz J. Nonsense-mediated mRNA decay: inter-individual variability and human disease. Neurosci Biobehav Rev. 2014;46 Pt 2:175\u2013186.","DOI":"10.1016\/j.neubiorev.2013.10.016"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-02979-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02979-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02979-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T05:02:08Z","timestamp":1786597328000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-02979-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":142,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2979"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-02979-w","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"10 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"440"}}